The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.

Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have ...

And lest the wanna-be bullies of public relations (like those called out in a 2021 Mother Jones’ barnburner Amazon exposé) ...

A Federal Trade Commission (FTC) report found that social and video streaming services pose serious privacy risks, especially ...

The Federal Trade Commission (FTC) on Friday sued the three largest pharmacy benefit managers (PBMs) for engaging in alleged ...

U.S. Federal Trade Commission Chair Lina Khan on Friday welcomed that companies are weighing antitrust considerations early ...

The Federal Trade Commission sued the drug middlemen that health plans use to keep a lid on drug spending, accusing the firms ...

The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of ...

On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...

Months earlier, the agency released a report alleging the companies drove up the costs of some medications, including insulin ...

Cigna Group’s Express Scripts sued the US Federal Trade Commission over a recent report that the company said demonizes ...

The three price benefit managers jointly administer 80% of all prescriptions in the U.S., the FTC said in the lawsuit.